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Background: Treatment of STEMI has considerably evolved over the past 2 decades.
However, predictors of adverse events after STEMI are mostly based on early studies
without consistent use of reperfusion therapy, P2Y12 inhibitors, and drug-eluting stent
implantation. We aimed to identify predictors of adverse events among patients with
ST-elevation myocardial infarction (STEMI) undergoing contemporary primary
percutaneous coronary intervention (PCI).
Methods: Individual data of 2655 patients from 2 primary PCI trials (EXAMINA-
TION, N¼1504; COMFORTABLE-AMI, N¼1161) with identical endpoint deﬁnition
and event adjudication were pooled. Predictors of patient-oriented (death or rein-
farction) and device-oriented (deﬁnite stent thrombosis [ST] and target-lesion revas-
cularization [TLR]) outcomes at 1 year were identiﬁed by multivariable Cox
regressions analysis.
Results: Killip class III/IV was the strongest predictor of death or reinfarction
(OR5.11, 95%CI2.48-10.52), ST (OR7.74, 95%CI2.87-20.93), and any TLR
(OR2.88, 95%CI1.17-7.06). Impaired LVEF (OR4.77, 95%CI2.10-10.82), ﬁnal TIMI
ﬂow 0-2 (OR1.93, 95%CI1.05-3.54), hypertension (OR1.69, 95%CI1.11-2.59), age
(OR1.68, 95%CI1.41-2.01), and peak CK (OR1.25, 95%CI1.02-1.54) were inde-
pendent predictors of death or reinfarction. Allocation to treatment with DES was an
independent predictor of a lower risk of ST (OR0.35, 95%CI0.16-0.74) and any TLR
(OR0.34, 95%CI0.21-0.54).Initial
management
Coronary angiography 493 (89%) (99%) <0.0001
Radial access* 140 (28%)
1511
(34%) <0.0001
Primary angioplasty* 386 (78%)
3197
(72%) 0.4
Thrombo aspiration* 163 (33%)
1874
(42%) <0.0001
Intra hospital
outcome
High degree AV block 40 (7%) 140 (3%) <0.0001
Atrial ﬁbrillation 59 (10%) 161
(3.6%)
<0.0001
Left ventricular ejection
fraction (%)
47.212 50.610 <0.0001
Total length of stay (days) 8.25 6.84 <0.0001
Prescription at
discharge
Aspirin 439 (96%) 4167
(98%)
0.007
Clopidogrel/Prasugrel 413 (90%) 4086
(96%)
<0.0001
b blockers 394 (86%) 3895
(91%)
<0.0001
ACE inhibitor 290 (63%) 2853
(67%)
0.1
Statin 373 (81%) 4057
(95%)
<0.0001
Conclusions: Killip class remains the strongest predictor of death or reinfarction
among STEMI patients undergoing primary PCI. Noteworthy, DES use independently
predicts a lower risk of TLR and deﬁnite ST.B70 JACC Vol 62/18/Suppl B j October 2TCT-217
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Background: Octogenarian represent a large part of ST-segment elevation myocardial
infarction (STEMI) patients. The present study aimed at determine their characteris-
tics, current management and prognosis.
Methods: We analyzed data collected in the “ORBI” registry, a 6-years prospective
registry of STEMI patients admitted within 24 hours of symptoms'onset to an inter-
ventional cardiology centre of Brittany (France). Main data about management, intra
hospital outcome and prescription at discharge were compared between patients older
(Group 1) and younger (Group 2) than 80, with a univariate analysis. We then
calculated adjusted odds ratio for intra hospital mortality (group 1 vs group 2) when
considering data about the patient, the delays and various aspect of revascularization.
Results: Among 5000 patients included, 550 (11%, mean age 84.63) constituted
group 1, with a larger female prevalence (51 vs 20% in group 2, p<0.0001). Group 1
had a much longer median delay between onset of symptom and call for medical
assistance (65 vs 45 min. in group 2, p<0.0001), and between admission and reper-
fusion (53 vs 45 min. in group 2, p¼0.01). Table 1 presents data about the
management in both groups, both in the acute phase and at discharge. Group 1 had
a signiﬁcantly higher intra hospital mortality (16.5 vs 4.1% in group 2, p<0.0001).
Moreover, the adjusted odd ratio for intra hospital mortality (group 1 vs group 2) was
2.73 [95% conﬁdence limits 1.83-4.07], p<0.0001.Cardiovascular
rehabilitation
22 (5%) 1822
(47%)
<0.0001
*Percentages are calculated only in patients undergoing coronary angiography.Conclusions: Octogenarian patients and more represent a large part of patients treated
for STEMI, with signiﬁcant differences in their presentation and management, and
a higher intra hospital mortality. Moreover, this higher mortality rate persists after
adjustment for patient characteristics, delays of coronary reperfusion, and manage-
ment of revascularization.7–November 1, 2013 j TCT Abstracts/POSTER/STEMI/NSTEMI/ACS
